CrosswordNewsletters
DAILY BEAST
ALL
  • Cheat Sheet
  • Politics
  • Crime
  • Entertainment
  • Media
  • Innovation
  • Opinion
  • World
  • U.S. News
  • Scouted
  • Travel
CHEAT SHEET
    POLITICS
    • Biden World
    • Elections
    • Opinion
    • National Security
    • Congress
    • Pay Dirt
    • The New Abnormal
    • Right Richter
    • Trumpland
    MEDIA
    • Daytime Talk
    • Late-Night
    • Fox News
    U.S. NEWS
    • Identities
    • Crime
    • Race
    • LGBT
    • Extremism
    • Coronavirus
    WORLD
    • Russia
    • Europe
    • China
    • Middle East
    SCIENCE
    • Hunt for the Cure
    • Rabbit Hole
    TRAVEL
      ENTERTAINMENT
      • TV
      • Movies
      • Music
      • Comedy
      • Sports
      • Sex
      • TDBs Obsessed
      • Awards Shows
      • The Last Laugh
      HALF-FULL
        CULTURE
        • Power Trip
        • Fashion
        • Books
        • Royalist
        TECH
        • Disinformation
        SCOUTED
        • Face Masks
        • Clothing
        • Technology
        • Bedroom
        • Kitchen
        • Home
        • Fitness
        • The Case For
        • I'm Looking For
        • New Kids On the Block
        COUPONS
        • Adidas Promo Codes
        • DoorDash Promo Codes
        • H&M Coupons
        • Hotwire Promo Codes
        • Wine.com Discounts
        • Vitacost Coupons
        • Spanx Promo Codes
        • StubHub Promo Codes
        Products
        NewslettersPodcastsCrosswordsSubscription
        FOLLOW US
        GOT A TIP?

        SEARCH

        HOMEPAGE
        Hunt for the Cure

        Creating Biosimilars Is So Much More Than Copy and Paste

        Highly Similar

        Biosimilars have the potential to expand patient access to more treatment options, but creating them is anything but copy and paste.

        Ad by Pfizer
        Updated Oct. 15, 2018 5:13PM ET / Published Jun. 25, 2018 2:00PM ET 

        Medicines produced from the cells of living organisms are called biologics. They’re typically more difficult to manufacture than small-molecule drugs, and generics, or exact copies, can’t be produced. This is where biosimilars come into play.

        Biosimilars are medicines that are highly similar to FDA-approved biologics and have no clinically meaningful differences in quality, safety, or efficacy. The benefits are that they are priced lower than their reference biologics, which may help to expand patient access to more treatment options and generate cost savings for healthcare systems.

        Joe McClellan is passionate about this development, seeing the potential biosimilars have to change patients’ lives. Check out the above video to learn more about biosimilars and watch all the episodes of Cure Hunters.

        More Cure Hunters episodes:

        Episode 1 | How Are Medicines Made?

        Episode 2 | Harnessing The Immune System To Fight Cancer

        Episode 3 | The Itch That Rashes

        Episode 4 | NASH: The Silent Killer

        Episode 5 | Precision Medicine: Targeting Cancer At The Source

        Episode 7 | Hunting Rare Diseases

        Episode 8 | Take Your Breath Away

        Episode 9 | Clinical Trials: Driving The Hunt Forward

        Episode 10 | A Constant Threat

        Episode 11 | Engineering Health

        READ THIS LIST

        DAILY BEAST
        • Podcasts
        • Cheat Sheet
        • Politics
        • Crime
        • Entertainment
        • Media
        • Covid-19
        • Half Full
        • U.S. News
        • Scouted
        • Travel
        • Subscription
        • Crossword
        • Newsletters
        • Podcasts
        • About
        • Contact
        • Tips
        • Jobs
        • Advertise
        • Help
        • Privacy
        • Code of Ethics & Standards
        • Diversity
        • Terms & Conditions
        • Copyright & Trademark
        • Sitemap
        • Coupons
        © 2022 The Daily Beast Company LLC